Drug approval delays in hematologic malignancies between Europe and the US and between Japan and the US: a clinical perspective.
Kensuke MatsudaSumimasa NagaiKoichi SugimotoPublished in: Japanese journal of clinical oncology (2023)
The current study provided data that can be used as a basis for discussion on how to improve drug approval delays in drugs for hematologic malignancies.